Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2000
08/16/2000CN1055473C 1,9-bridged thiazolo (3,2-A) quinoline derivatives
08/16/2000CN1055469C Optically pure salts of pyridinylmethyl sulfinyl-1H-benzimidazole compounds, its preparing method and use
08/16/2000CN1055390C Process for preparing pharmaceutical composition having synergistic effect
08/15/2000US6103936 Reacting aldehyde, sulfide, sulfone, or sulfoxide with formamide in presence of acid catalyst, and optionally a dehydrating agent
08/15/2000US6103922 Anti-viral compounds
08/15/2000US6103909 Azole compounds endowed with antimycotic activity for human and veterinary use
08/15/2000US6103907 Phenylalkylcarboxylic acid compounds and compositions for treating hyperglycemia
08/15/2000US6103897 Crystallization of amoxicillin salt from ethanolic solution containing amoxicillin and alkali or alkaline earth alcoholate or carboxylate; by-product inhibition
08/15/2000US6103883 Glycolipid mimics and methods of use thereof
08/15/2000US6103877 Purified antibody which specifically binds to human hypermethylated in cancer-1 polypeptide of specific amino acid sequence or its immunoreactive fragments; for diagnosis/ prognosis of cell proliferative disorders such as cancer
08/15/2000US6103737 Aryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonists
08/15/2000US6103727 Pyrimidine derivatives and methods of making and using these derivatives
08/15/2000US6103716 Bactericides; administering my mouth to mammals and humans; prophylaxis; cattle, sheep, swine, poultry
08/15/2000US6103710 Glucocorticoid response elements
08/15/2000US6103527 Nucleotide sequence from gene expressed in proliferating endothelial cells; for controlled gene expression especially for transgenic tissues and gene therapy
08/15/2000US6103519 Recombinant dna including coding sequence and regulatory sequence for expression of l protein with modified or deleted regions; for hepatitis vaccines
08/15/2000US6103513 Novel proteolytic enzyme; for the treatment of immune, proliferative and degratory defects
08/15/2000US6103244 Containing a heterologous insert encoding an immunogenic protein, wherein said insert was molecularly cloned directly into the viral genome into a unique restriction endonuclease cleavage site
08/15/2000US6103239 Modified HGP-30 heteroconjugates, compositions and methods of use
08/15/2000US6103238 Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines
08/15/2000US6102254 Pharmaceutical compositions in semisolid form and a device for administration thereof
08/15/2000CA2287056C Orally administrable solid ribavirin dosage forms and process for making them
08/15/2000CA2202280C Sugar modified nucleosides and their use for synthesis of oligonucleotides
08/15/2000CA2153391C Inducing cytotoxic t lymphocyte responses
08/10/2000WO2000046389A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method
08/10/2000WO2000046352A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof
08/10/2000WO2000046253A1 Process for the production of multiple cross-linked hyaluronic acid derivatives
08/10/2000WO2000046251A2 Human polyclonal antibodies from transgenic nonhuman animals
08/10/2000WO2000046248A1 Use of agonists or antagonists of mip-3a in therapy
08/10/2000WO2000046223A1 Tricyclic quinolonecarboxylic acid derivatives or salts thereof
08/10/2000WO2000046215A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
08/10/2000WO2000045851A2 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
08/10/2000WO2000045847A1 Novel mucosal delivery system
08/10/2000WO2000045844A1 Use of hydroxyurea and a reverse transcriptase inhibitor to induce autovaccination by autologous hiv
08/10/2000WO2000045841A2 Human papilloma virus vaccine formulations
08/10/2000WO2000045840A1 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence
08/10/2000WO2000045836A1 Uses of thank, a tnf homologue that activates apoptosis
08/10/2000WO2000045835A1 Vascular endothelial growth factor-2
08/10/2000WO2000045833A1 Hiv drug resistance system
08/10/2000WO2000045823A1 Electrically-mediated enhancement of dna vaccine immunity and efficacy in vivo
08/10/2000WO2000045808A1 Preparation for warts
08/10/2000WO2000045803A2 Use of 5-aminosalicylates as antimicrobial agents
08/10/2000WO2000045791A2 Method for controlling liposome size
08/10/2000WO2000029008A3 Hiv-specific t-cell induction
08/10/2000WO2000026399A3 Method for the production of quercetin and isoquercetin derivatives
08/10/2000WO2000026239A3 $i(chlamydia) antigens and corresponding dna fragments and uses thereof
08/10/2000WO2000024911A3 Human phospholipases
08/10/2000WO2000024773A3 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
08/10/2000WO2000016746A8 Immunogenic liposome compositions
08/10/2000WO2000012509B1 Collections of compounds
08/10/2000WO2000010599A8 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
08/10/2000WO2000006197A8 Combined vaccine for immunoprophylaxis against viral hepatitis b and d, tetanus and diphtheria
08/10/2000WO1999008706A8 Recombinant porcine adenovirus vector
08/10/2000DE19905278A1 Oxazolidinone und ihre Verwendung als antibakterielle Mittel Oxazolidinones and their use as antibacterial agents
08/10/2000DE19905128A1 New human antibiotic peptides, useful for treating microbial infections, particularly when incorporated in wound dressings, also related nucleic acid
08/10/2000CA2361615A1 The use of vascular endothelial growth factor 2 antagonist in the treatment of an injury to or disorder of an eye
08/10/2000CA2361601A1 Electrically-mediated enhancement of dna vaccine immunity and efficacy in vivo
08/10/2000CA2361551A1 Method for controlling liposome size
08/10/2000CA2360942A1 Preparations for preventing and/or treating a tissue change of mesenchymal origin
08/10/2000CA2360865A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method
08/10/2000CA2360688A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof
08/10/2000CA2359469A1 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence
08/10/2000CA2358855A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
08/09/2000EP1026253A2 Expression of exogenous polynucleotide sequences in a vertebrate
08/09/2000EP1026252A1 Synthetic gene of bovine viral diarrhoea virus
08/09/2000EP1026246A1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same
08/09/2000EP1026245A1 Antigen protein and nucleic acid coding for said protein
08/09/2000EP1026170A1 Erythromycin derivatives, their preparation and use as medicaments
08/09/2000EP1025856A2 Methods for modulating T Cell unresponsiveness
08/09/2000EP1025212A2 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
08/09/2000EP1025124A1 Low-toxicity human interferon-alpha analogues
08/09/2000EP1025116A1 Estra-1,3,5(10)-triene-7alpha-thioethers
08/09/2000EP1025114A1 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
08/09/2000EP1025102A1 Bicyclic kinase inhibitors
08/09/2000EP1024836A1 Method of delivering genes to antigen presenting cells of the skin
08/09/2000EP1024835A1 J-chain and analogues as epithelial cell targeting conjugates
08/09/2000EP1024831A2 Application of tnf antagonists as medicaments for treating septic diseases
08/09/2000EP1024828A1 NOVEL pheS (BETA)
08/09/2000EP1024827A1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents
08/09/2000EP1024826A1 PASSIVE IMMUNIZATION AGAINST $i(CLOSTRIDIUM DIFFICILE) DISEASE
08/09/2000EP1024821A1 Novel prokaryotic polynucleotides, polypeptides and their uses
08/09/2000EP1024814A2 Use of antifungal agents for the topical treatment of fungus-induced mucositis
08/09/2000EP1024809A1 Use of immunomodulating agents
08/09/2000EP1024792A1 Topical antifungal composition
08/09/2000EP0786083B1 Diagnosis and monitoring process, and medicaments for the therapy of states of shock in human beings
08/09/2000EP0759780B1 Improved modified live brsv vaccine
08/09/2000EP0642513B1 Indolocarbazole imides and their use
08/09/2000CN1262686A Organic compound
08/09/2000CN1262684A 2,4,4-trisubstituted-1,3-dioxolane antifungals
08/09/2000CN1262682A Itraconazole with improved solubility, method of preparing same and pharmaceutical composition for oral administration comprising same
08/09/2000CN1262675A (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers
08/09/2000CN1262273A Process for preparing guanine by pressing
08/09/2000CN1262272A HIV proteinase inhibitor
08/09/2000CN1262129A Pig erysipelothrix rhusiopathiae antigen and vaccine composition thereof
08/09/2000CN1055241C Medicine for pulmonary tuberculosis and its preparation process
08/09/2000CN1055229C Medicine for parotitis and its prepn process
08/09/2000CN1055224C Chinese medicine for treatment of tuberculosis
08/08/2000US6100426 Anti-viral compounds
08/08/2000US6100409 Hydroxy and polyhydroxy derivatives of coumarin, preparation thereof and antiviral action thereof
08/08/2000US6100404 Erythromycin compounds
1 ... 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 ... 1798